NANCY T CHANG
CIK 1135041 · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$14.51M
Companies
4
Total Filings
25
Lifetime Open-Market Net
-$107.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WTI | Director | 216,100 | $4.06 | $877.4K | $0 | 4 | 2026-06-05 |
| IMMX | Director | 925,130 | $8.45 | $7.82M | $0 | 2 | 2026-05-29 |
| SCICLONE PHARMACEUTICALS INC (SCLN) Delisted | Director | 0 | — | — | -$107.7K | 9 | 2017-10-16 |
| CRL | Director | 31,010 | $187.51 | $5.81M | $0 | 7 | 2010-05-11 |
Recent Filings · Page 3 of 3
25 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-11-19 | CRL | Grant (A) | +10,500 | $250.5K | EDGAR |
| 2008-05-13 | CRL | Grant (A) | +2,000 | $0 | EDGAR |
| 2008-05-13 | CRL | Grant (A) | +3,000 | $0 | EDGAR |
| 2008-02-26 | CRL | Grant (A) | +10,000 | $573.7K | EDGAR |
| 2007-11-02 | CRL | Grant (A) | +3,000 | $0 | EDGAR |
Showing 21–25 of 25
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.